Pharmafile Logo

bedaquiline

- PMLiVE

Janssen reveals positive results for nipocalimab in rheumatoid arthritis

About 13 million people worldwide are affected by the chronic inflammatory disease

- PMLiVE

Moderna and CEPI enter pandemic preparedness partnership

The partnership aims to expand infectious disease targets for mRNA vaccine technology

- PMLiVE

Infographic: Rare Diseases in China

How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider.

Research Partnership

- PMLiVE

NIHR launches new framework to highlight health progress outcomes

Over 400 partners and stakeholders collaborated to develop the new framework

- PMLiVE

Landscape review reveals £1.1bn of UK funding for rare diseases

The report focuses on future funding and needs for those with rare diseases

- PMLiVE

CDC provides $262.5m to create national network for infectious diseases

The OADMN aims to improve responses to outbreaks and prevent future pandemics

- PMLiVE

CDC awards over $23m to Johns Hopkins Center for Health Security project

The five-year grant will be used to help launch a new epidemic preparedness project

- PMLiVE

Clinigen launches educational programme for rare disease patients and organisations

The NaviGATE programme will aim to empower patients and provide navigational support

- PMLiVE

Janssen’s Tecvayli approved by EC for reduced dosing frequency in multiple myeloma

Tecvayli was the first BCMA-targeting bispecific antibody to be approved in Europe

- PMLiVE

Medscape Education Launches 20th Older Driver Safety Educational Program

Education Supported by the National Highway Traffic Safety Administration

Medscape Education Global

regeneron headquarters

Regeneron’s Veopoz granted FDA approval for ultra-rare immune disease

Fewer than ten patients in the US have been diagnosed with CHAPLE disease

- PMLiVE

UK government allocates £250m for more NHS hospital beds in England

The funds will provide another 5,000 beds this winter to relieve pressure on hospitals and cut waiting times

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links